# HEPACAM

## Overview
HEPACAM, also known as GlialCAM, is a gene that encodes the hepatic and glial cell adhesion molecule, a member of the immunoglobulin superfamily. This protein is characterized by its role as a transmembrane cell adhesion molecule, which is crucial for maintaining cellular junctions and communication. It is involved in the stabilization and localization of connexin 43, a key component of gap junctions, thereby playing a significant role in cell-cell communication and tumor suppression (Baldwin2021HepaCAM; Wu2016HepaCAM). HEPACAM is also implicated in the regulation of cell adhesion and migration, influencing processes such as astrocyte morphogenesis and synaptic function (Baldwin2021HepaCAM). Mutations in the HEPACAM gene are associated with the neurodegenerative disorder megalencephalic leukoencephalopathy with subcortical cysts (MLC), highlighting its importance in maintaining normal brain function (BarralloGimeno2013GLIALCAM). Additionally, the gene's expression is often downregulated in various cancers, underscoring its potential role as a tumor suppressor (Du2015Expression).

## Structure
HepaCAM, also known as GlialCAM, is a member of the immunoglobulin superfamily and is characterized by its structure, which includes an extracellular domain with two immunoglobulin-like loops, a transmembrane segment, and a cytoplasmic tail (Lee2009The; Wu2016HepaCAM). The protein is 416 amino acids long and is encoded by a gene located on chromosome 11q24 (He2010Functional). HepaCAM is known to form cis-homodimers on the cell surface, which is a feature of its quaternary structure (Lee2009The).

The protein undergoes post-translational modifications, including glycosylation and phosphorylation, which are crucial for its function. Glycosylation is a common modification that supports its role on the exosomal surface, with the glycosylated form detected at approximately 70 kDa (Lee2009The; Jin2023Astroglial). The cytoplasmic domain is phosphorylated and plays a significant role in its biological functions, particularly in cancer suppression (Deng2019HepaCAM).

HepaCAM's extracellular domain is essential for its adhesive function and interaction with other proteins, such as connexin 43 and MLC1, which are important for its role in cellular junctions and signaling (Baldwin2021HepaCAM; Wu2016HepaCAM).

## Function
HEPACAM, also known as GlialCAM, is a cell adhesion molecule that plays a crucial role in maintaining cellular processes in healthy human cells. It is involved in the localization and stabilization of connexin 43, a major component of gap junctions, at cellular junctions. This stabilization is essential for maintaining cell-cell communication, as connexin 43 is known for its anti-tumor activity. In the absence of HEPACAM, connexin 43 undergoes faster degradation via the lysosomal pathway, which can impair cellular communication (Wu2016HepaCAM).

HEPACAM is also involved in regulating cell adhesion and migration, processes vital for normal development and tissue integrity. It forms homophilic interactions to facilitate the targeting of transmembrane proteins to cell-cell junctions, including MLC1 and the chloride channel ClC-2, for which it serves as an auxiliary subunit (Baldwin2021HepaCAM). In astrocytes, HEPACAM is essential for morphogenesis and competition for territory, influencing the balance between synaptic excitation and inhibition (Baldwin2021HepaCAM).

HEPACAM's role extends to the nervous system, where it is involved in astrocyte self-organization and coupling, impacting synaptic function and gap junction coupling. Its function at inhibitory synapses may be independent of connexin 43, potentially involving its role as an auxiliary chloride channel subunit (Baldwin2021HepaCAM).

## Clinical Significance
Mutations in the HEPACAM gene, also known as GlialCAM, are linked to the neurodegenerative disease megalencephalic leukoencephalopathy with subcortical cysts (MLC). This condition is characterized by macrocephaly, white matter swelling, and subcortical cysts, often leading to cognitive decline and epilepsy. Mutations in HEPACAM disrupt its interaction with the MLC1 protein, affecting its localization to astrocytic junctions, which is crucial for maintaining normal brain function (Baldwin2021HepaCAM; Wu2016HepaCAM; BarralloGimeno2013GLIALCAM).

HEPACAM is also implicated in various cancers, where its expression is frequently downregulated. In bladder cancer, HEPACAM expression is silenced by hypermethylation, and its reexpression can reduce cell growth, indicating its role as a tumor suppressor. This downregulation is observed in other carcinomas, including hepatocellular, breast, kidney, colon, rectum, and stomach cancers (Du2015Expression; Wu2016HepaCAM).

HEPACAM's interaction with connexin 43, a major component of gap junctions, is crucial for its tumor-suppressing activity. Mutations in HEPACAM that cause MLC or its neutralization with antibodies disrupt this association, affecting connexin 43's localization and stability at cellular junctions (Wu2016HepaCAM).

## Interactions
HEPACAM, also known as GlialCAM, is involved in several physical interactions with other proteins, playing a significant role in cellular junctions and signaling pathways. It associates with connexin 43 (Cx43), a major component of gap junctions, enhancing its localization to the plasma membrane at cellular junctions. This interaction stabilizes Cx43, preventing its degradation via the lysosomal pathway (Wu2016HepaCAM). Mutations in HEPACAM, such as R92Q and R92W, disrupt its association with Cx43, reducing the protein's stability and membrane localization (Wu2016HepaCAM).

HEPACAM also interacts with MLC1, facilitating its shuttling to the cell membrane, and associates with the chloride channel ClC-2, serving as an auxiliary subunit (Baldwin2021HepaCAM; Wu2016HepaCAM). These interactions suggest that HEPACAM acts as a general regulator of cellular junctions, enhancing the stability and membrane localization of these proteins (Wu2016HepaCAM).

In astrocytes, HEPACAM is crucial for the localization and stability of Cx43, affecting astrocyte morphogenesis and gap junction coupling. The loss of HEPACAM impairs these processes, highlighting its role in astrocyte self-organization and synaptic function (Baldwin2021HepaCAM).


## References


[1. (He2010Functional) Yunfeng He, Xiaohou Wu, Chunli Luo, Lie Wang, and Jie Lin. Functional significance of the hepacam gene in bladder cancer. BMC Cancer, March 2010. URL: http://dx.doi.org/10.1186/1471-2407-10-83, doi:10.1186/1471-2407-10-83. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2407-10-83)

[2. (Wu2016HepaCAM) Meihui Wu, Mei Chung Moh, and Herbert Schwarz. Hepacam associates with connexin 43 and enhances its localization in cellular junctions. Scientific Reports, November 2016. URL: http://dx.doi.org/10.1038/srep36218, doi:10.1038/srep36218. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep36218)

[3. (BarralloGimeno2013GLIALCAM) Alejandro Barrallo-Gimeno and Raúl Estévez. GLIALCAM, A Glial Cell Adhesion Molecule Implicated in Neurological Disease, pages 47–59. Springer New York, October 2013. URL: http://dx.doi.org/10.1007/978-1-4614-8090-7_3, doi:10.1007/978-1-4614-8090-7_3. This article has 8 citations.](https://doi.org/10.1007/978-1-4614-8090-7_3)

[4. (Baldwin2021HepaCAM) Katherine T. Baldwin, Christabel X. Tan, Samuel T. Strader, Changyu Jiang, Justin T. Savage, Xabier Elorza-Vidal, Ximena Contreras, Thomas Rülicke, Simon Hippenmeyer, Raúl Estévez, Ru-Rong Ji, and Cagla Eroglu. Hepacam controls astrocyte self-organization and coupling. Neuron, 109(15):2427-2442.e10, August 2021. URL: http://dx.doi.org/10.1016/j.neuron.2021.05.025, doi:10.1016/j.neuron.2021.05.025. This article has 60 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2021.05.025)

[5. (Deng2019HepaCAM) Qingfu Deng, Li Luo, Zhen Quan, Nanjing Liu, Zhongbo Du, Wei Sun, Chunli Luo, and Xiaohou Wu. Hepacam inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain. Molecular Medicine Reports, January 2019. URL: http://dx.doi.org/10.3892/mmr.2019.9841, doi:10.3892/mmr.2019.9841. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2019.9841)

[6. (Du2015Expression) Hong-Fei Du, Li-Ping Ou, Chang-Kun Lv, Xue Yang, Xue-Dong Song, Yan-Ru Fan, Xiao-Hou Wu, and Chun-Li Luo. Expression of hepacam inhibits bladder cancer cell proliferation via a wnt/β-catenin-dependent pathwayin vitroandin vivo. Cancer Biology &amp; Therapy, 16(10):1502–1513, July 2015. URL: http://dx.doi.org/10.1080/15384047.2015.1071732, doi:10.1080/15384047.2015.1071732. This article has 17 citations.](https://doi.org/10.1080/15384047.2015.1071732)

7. (Jin2023Astroglial) Astroglial exosome HepaCAM signaling and ApoE antagonization coordinates early postnatal cortical pyramidal neuronal axon growth and dendritic spine formation. This article has 0 citations.

[8. (Lee2009The) Lay Hoon Lee, Mei Chung Moh, Ting Zhang, and Shali Shen. The immunoglobulin‐like cell adhesion molecule hepacam induces differentiation of human glioblastoma u373‐mg cells. Journal of Cellular Biochemistry, 107(6):1129–1138, June 2009. URL: http://dx.doi.org/10.1002/jcb.22215, doi:10.1002/jcb.22215. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.22215)